These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6129644)

  • 1. Similar antagonism of morphine analgesia by MIF-1 and naloxone in Carassius auratus.
    Ehrensing RH; Michell GF; Kastin AJ
    Pharmacol Biochem Behav; 1982 Oct; 17(4):757-61. PubMed ID: 6129644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIF-1 and Tyr-MIF-1 antagonize morphine and opioid but not non-opioid stress-induced analgesia in the snail, Cepaea nemoralis.
    Kavaliers M
    Peptides; 1987; 8(1):1-5. PubMed ID: 2883631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of morphine analgesia by prolyl-leucyl-glycinamide (MIF-1) in humans.
    Ehrensing RH; Kastin AJ; Michell GF
    Pharmacol Biochem Behav; 1984 Dec; 21(6):975-8. PubMed ID: 6151672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of morphine analgesia by alpha-MSH, MIF-I, melatonin and naloxone in the rat.
    Datta PC; Sandman CA; Hoehler FK
    Peptides; 1982; 3(3):433-7. PubMed ID: 6126866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1984 Jun; 102(1):13-22. PubMed ID: 6148243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl-leucyl-glycinamide reduces aggression and blocks defeat-induced opioid analgesia in mice.
    Teskey GC; Kavaliers M
    Peptides; 1985; 6(2):165-7. PubMed ID: 2863808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of morphine-induced tolerance and physical dependence by prolyl-leucyl-glycinamide.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1981 May; 71(2-3):259-68. PubMed ID: 6113968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
    Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
    Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory influences of MIF-1 (PLG) and Tyr-MIF-1 (YPLG) on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Hirst M
    Peptides; 1986; 7(6):1007-10. PubMed ID: 2882493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine.
    Yehuda S; Kastin AJ; Coy DH
    Int J Neurosci; 1980; 11(4):317-20. PubMed ID: 6108937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone-like actions of MIF-1 do not require the presence of the pituitary.
    Kastin AJ; Nissen C; Zadina JE; Schally AV; Ehrensing RH
    Pharmacol Biochem Behav; 1980 Dec; 13(6):907-12. PubMed ID: 6111087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of narcotic tolerance and physical dependence: effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN; Walter R; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Jan; 12(1):73-7. PubMed ID: 6102769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors.
    Bhargava HN; Pandey RN; Matwyshyn GA
    Life Sci; 1983 May; 32(18):2096-101. PubMed ID: 6133201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic peptide hormone, prolyl-leucyl-glycinamide and analog, inhibit tolerance to the analgesic and locomotor depressant but not to the locomotor stimulant effects of morphine in the mouse.
    Bhargava HN
    Neuropharmacology; 1982 Mar; 21(3):227-33. PubMed ID: 6122186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog.
    Sander GE; Kastin AJ; Giles TD
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1301-3. PubMed ID: 6131437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptor antagonism by L-prolyl-L-leucyl-glycinamide, MIF-I.
    Dickinson SL; Slater P
    Peptides; 1980; 1(4):293-9. PubMed ID: 6117839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.